Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children
NCT: NCT03339037 · TERMINATED
Brief Summary
Due its high incidence, mTBI and its consequences of PPCS are a major public health issue. There is no consensus regarding the treatment of PPCS in pediatrics. Relying on its results in adults, HBOT offers a promising new direction of treatment, which targets the basic pathological processes responsible for post-concussion symptoms. The effect of hyperbaric oxygen therapy in pediatric TBI has never been evaluated. The aim of the current study is to evaluate in a prospective cross-over, randomized study, the effect of HBOT on children with PPCS due to mild TBI.
Frequently Asked Questions
What is Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children?
Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children is a clinical trial registered under NCT03339037. Current status: TERMINATED.
What is the status of NCT03339037?
The current status of NCT03339037 (Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children) is: TERMINATED.
When did Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children start?
Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children started on 2017-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.